Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?

被引:7
|
作者
Rizzoni, Damiano [1 ]
Agabiti-Rosei, Claudia [1 ,2 ]
Boari, Gianluca E. M. [3 ]
Muiesan, Maria Lorenza [1 ,2 ]
De Ciuceis, Carolina [1 ,2 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, I-25121 Brescia, Italy
[2] Spedali Civili Brescia, Div Med 2, I-25123 Brescia, Italy
[3] Spedali Civili Brescia, Div Med, I-25123 Brescia, Italy
关键词
microcirculation; peripheral circulation; remodeling; small resistance arteries; vascular biology; SMALL-ARTERY STRUCTURE; SMALL-RESISTANCE ARTERIES; TO-LUMEN RATIO; SUBCUTANEOUS SMALL ARTERIES; II-INDUCED HYPERTENSION; RETINAL ARTERIOLES; BLOOD-PRESSURE; MICROVASCULAR STRUCTURE; STRUCTURAL ALTERATIONS; OXIDATIVE STRESS;
D O I
10.3390/jcm12154892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arterial hypertension is a common condition worldwide and an important risk factor for cardio- and cerebrovascular events, renal diseases, as well as microvascular eye diseases. Established hypertension leads to the chronic vasoconstriction of small arteries as well as to a decreased lumen diameter and the thickening of the arterial media or wall with a consequent increased media-to-lumen ratio (MLR) or wall-to-lumen ratio (WLR). This process, defined as vascular remodeling, was firstly demonstrated in small resistance arteries isolated from subcutaneous biopsies and measured by micromyography, and this is still considered the gold-standard method for the assessment of structural alterations in small resistance arteries; however, microvascular remodeling seems to represent a generalized phenomenon. An increased MLR may impair the organ flow reserve, playing a crucial role in the maintenance and, probably, also in the progressive worsening of hypertensive disease, as well as in the development of hypertension-mediated organ damage and related cardiovascular events, thus possessing a relevant prognostic relevance. New non-invasive techniques, such as scanning laser Doppler flowmetry or adaptive optics, are presently under development, focusing mainly on the evaluation of WLR in retinal arterioles; recently, also retinal microvascular WLR was demonstrated to have a prognostic impact in terms of cardio- and cerebrovascular events. A rarefaction of the capillary network has also been reported in hypertension, which may contribute to flow reduction in and impairment of oxygen delivery to different tissues. These microvascular alterations seem to represent an early step in hypertension-mediated organ damage since they might contribute to microvascular angina, stroke, and renal dysfunction. In addition, they can be markers useful in monitoring the beneficial effects of antihypertensive treatment. Additionally, conductance arteries may be affected by a remodeling process in hypertension, and an interrelationship is present in the structural changes in small and large conductance arteries. The review addresses the possible relations between structural microvascular alterations and hypertension-mediated organ damage, and their potential improvement with antihypertensive treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target
    Reiss, Allison B.
    Ahmed, Saba
    Johnson, Maryann
    Saeedullah, Usman
    De Leon, Joshua
    METABOLITES, 2023, 13 (04)
  • [32] Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
    Golia, Enrica
    Limongelli, Giuseppe
    Natale, Francesco
    Fimiani, Fabio
    Maddaloni, Valeria
    Pariggiano, Ivana
    Bianchi, Renatomaria
    Crisci, Mario
    D'Acierno, Ludovica
    Giordano, Roberto
    Di Palma, Gaetano
    Conte, Marianna
    Golino, Paolo
    Russo, Maria Giovanna
    Calabro, Raffaele
    Calabro, Paolo
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [33] The Coxsackie and Adenovirus Receptor as a therapeutic target in cardiovascular disease
    Hamann, W.
    Thakkar, M.
    Freiberg, F.
    Wrackmeyer, U.
    Fischer, R.
    Gotthardt, M.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [34] Lipoprotein[a]: a novel therapeutic target for cardiovascular disease management
    Ahmad, Muhammad
    Khan, Malik W. Z.
    Ali, Aizaz
    CARDIOLOGY IN THE YOUNG, 2024, 34 (07) : 1616 - 1617
  • [35] Endoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease
    Minamino, Tetsuo
    Komuro, Issei
    Kitakaze, Masafumi
    CIRCULATION RESEARCH, 2010, 107 (09) : 1071 - 1082
  • [36] The Emerging Role of MicroRNAs as a Therapeutic Target for Cardiovascular Disease
    Seok, Hee-Young
    Wang, Da-Zhi
    BIODRUGS, 2010, 24 (03) : 147 - 155
  • [37] Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease
    Zhang, Guangyu
    Wang, Xiaoding
    Gillette, Thomas G.
    Deng, Yingfeng
    Wang, Zhao, V
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (21) : 1902 - 1917
  • [38] PCSK9 as a therapeutic target for cardiovascular disease
    Zhang, Pei-Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 810 - 814
  • [39] Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions
    Doumas, Michael
    Guo, Daqing
    Papademetriou, Vasilios
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (04) : 413 - 425
  • [40] Diabetes, cardiovascular disease and the microcirculation
    W. David Strain
    P. M. Paldánius
    Cardiovascular Diabetology, 17